Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11957666 Regimen for suppressing organ rejection

Patent 11957666 was granted and assigned to Veloxis Pharmaceuticals on April, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Veloxis Pharmaceuticals
Veloxis Pharmaceuticals
0
Date Filed
September 14, 2021
0
Date of Patent
April 16, 2024
0
Patent Applicant
Veloxis Pharmaceuticals
Veloxis Pharmaceuticals
0
Patent Application Number
17447581
0
Patent Citations
‌
US Patent 9775834 Regimen for supressing organ rejection
0
‌
US Patent 10485793 Regimen for suppressing organ rejection
0
‌
US Patent 7994214 Solid dispersions comprising tacrolimus
0
‌
US Patent 8591946 Modified release compositions comprising tacrolimus
0
‌
US Patent 8664239 Tacrolimus for improved treatment of transplant patients
0
‌
US Patent 8685998 Tacrolimus for improved treatment of transplant patients
0
‌
US Patent 9168246 Regimen for suppressing organ rejection
0
Patent Inventor Names
William J. Polvino
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11957666
0
Patent Primary Examiner
‌
Raymond J. Henley, III
0
CPC Code
‌
A61K 31/435
0

Find more entities like US Patent 11957666 Regimen for suppressing organ rejection

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.